(18)FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report

Imatinib mesylate is a tyrosine kinase inhibitor of c-KIT and PDGFRA. Imatinib mesylate is an effective drug that can be used as a first-choice agent for treatment of GISTs. Prior to treatment, molecular diagnosis of c-KIT or PDGFRA is necessary; however, in some types of GISTs, it is impossible to...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Kazunori, Takahashi, Masahiro, Nanjo, Hiroshi, Miyazawa, Hideaki, Iida, Masatake, Abe, Yuki, Jin, Mario, Onishi, Hirohide, Hashimoto, Manabu, Yamamoto, Yuzo, Shibata, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350050/
https://www.ncbi.nlm.nih.gov/pubmed/22606444
http://dx.doi.org/10.1155/2011/638794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350050/
https://www.ncbi.nlm.nih.gov/pubmed/22606444
http://dx.doi.org/10.1155/2011/638794

Ejemplares similares